Cyclopal

This MedLibrary.org supplementary page on Cyclopal is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Cyclopal
Systematic (IUPAC) name
5-(1-cyclopent-2-enyl)-5-prop-2-enyl-1,3-
diazinane-2,4,6-trione
Identifiers
CAS number 76-68-6
ATC code  ?
PubChem 6454
Chemical data
Formula C12H14N2O3 
Mol. mass 234.251 g/mol
Synonyms Allylpental, Cyclopental, Dormisan, 5-Allyl-5-Δ2-Cyclopentenyl Barbituric Acid
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Cyclopal (Dormisan) is a barbiturate derivative invented in the 1940s. It has sedative and anticonvulsant properties, and was used primarily as an anaesthetic in veterinary medicine.[1] Cyclopal is considered similar in effects to phenobarbital but lasts almost three times as long, and is considered a long-acting barbiturate with a fairly slow onset of action.


References

  1. ^ Vander Brook MJ, Cartland GF. A Pharmacologic Study of 5-Allyl-5-Cyclopentenyl Barbituric Acid (Cyclopal). Journal of Pharmacology And Experimental Therapeutics, 1944, 80(2): 119-125

Wikipedia content modification information:

  • This page was last modified on 12 August 2008, at 19:44.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Cyclopal".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.